Acute myelomonoblastic leukemia carrying the PEBP2beta/MYH11 fusion gene.
As recurrent chromosome abnormalities in leukemia are highly associated with particular subtypes, the genetic events of specific chromosome alteration must be associated with leukemogenesis and characteristics of the disease. The chromosomal breakpoints involved in inv(16) and t(16;16) have been shown to generate the fusion gene PEBP2beta(CBFbeta)/MYH11. The PEBP2beta/MYH11 fusion transcripts in all 8 patients with M4Eo, 2 of 18 with M4, and one CML in the blastic phase were detected by using RT-PCR and Southern blotting. We demonstrated the marked expression of CD34 and c-KIT (CD117) antigens in myelomonoblastic leukemia cells from all patients carrying this fusion gene, which was in contrast to the patients with M4 but without the fusion gene. These results indicate that immunophenotypic analysis is useful for detection of leukemia with the fusion gene, and that the PEBP2beta/MYH11 fusion gene is involved in immature cells expressing CD34 and c-KIT antigens.
Second Department of Internal Medicine, Kumamoto University School of Medicine, Honjo, Japan. ktcnasou@kaiju.medic.kumamoto-u.ac.jp
N
N
Asou
M
M
Osato
T
T
Okubo
H
H
Yamasaki
K
K
Hoshino
S
S
Nishimura
T
T
Era
H
H
Suzushima
K
K
Takatsuki
D019677:Artificial Gene Fusion; D002454:Cell Differentiation / Q000502:physiology; D007446:Chromosome Inversion; D002885:Chromosomes, Human, Pair 16; D006801:Humans; D016130:Immunophenotyping; D015479:Leukemia, Myelomonocytic, Acute / Q000235:genetics* / Q000473:pathology; D014158:Transcription, Genetic; D014178:Translocation, Genetic